Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves New Dosing Schedule for Rybrevant Faspro
Published 3 months ago
Description
In today’s Pharmaceutical Executive Daily, the FDA approves a monthly dosing schedule for Rybrevant Faspro, HHS Secretary Robert F. Kennedy Jr. revises the agency’s leadership team, and industry expert Sandy Tammisetty discusses what it takes to deliver actual value in today’s pharmaceutical landscape.